4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0000950170-24-028788
Director sold 13,000 shares at an average $46.28 ($601,615)
From the SEC's structured data for this filing
Trades in this filing
GANNON STEVEN · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-07 | Sale : show line 1 in the form | −1,000 | $46.45 | $46,450 | 14,000 | D |
| 2024-03-07 | Sale : show line 2 in the form | −5,000 | $46.25 | $231,250 | 9,000 | D |
| 2024-03-07 | Sale : show line 3 in the form | −5,000 | $46.30 | $231,513 | 4,000 | D |
| 2024-03-07 | Sale : show line 4 in the form | −2,000 | $46.20 | $92,402 | 2,000 | D |
| Open-market sales · 13,000 sh · avg $46.28 · $601,615 | ||||||
Loading xslF345X05/ownership.xml…